跳至主要内容
临床试验/CTRI/2018/05/014174
CTRI/2018/05/014174已完成不适用

A randomised, placebo-controlled, double blind clinical trial to test whether study drug could decrease damage from oxidative stress and inflammation related to acute muscle injury induced by eccentric continuous exercise.

Plant Lipids P limited1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年5月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
To assess the efficacy of herbal preparation in patients with Delayed onset muscle soreness (DOMS) due to eccentric muscle activity.

研究概览

简要总结

Delayed onset muscle soreness (DOMS) is a familiar experience for the elite or novice athlete. Symptoms can range from muscle tenderness to severe debilitating pain. The mechanisms, treatment strategies, and impact on athletic performance remain uncertain, despite the high incidence of DOMS. DOMS is most prevalent at the beginning of the sporting season when athletes are returning to training following a period of reduced activity. DOMS is also common when athletes are first introduced to certain types of activities regardless of the time of year.

This problem can be trounced by innovative Curcumin preparation. It has been inferred that the test compound shows a concentration dependent DPPH free radical scavenging activity indicating its antioxidant potential equivalent to ascorbic acid. Based on the result in the study, it was concluded that the bio available curcumin-“cureit†could be a good source of natural antioxidant.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Age: more than 20 years 2.Subjects will be healthy, moderately active (regular aerobic exercise for at least 4 hours per week), non-smoking volunteers with no known musculoskeletal pathology.
  • 3.Subjects should have a maximal oxygen consumption (VO2max) of at least 35 ml/kg, as assessed by the maximal treadmill exercise test.
  • 4.Subjects willing to sign an informed consent and adhere to all protocol requirements.

排除标准

  • 1.Treatment with anti-inflammatory/analgesic/antioxidant drugs in the previous month, 2.Abnormal liver or renal function tests, laboratory findings suggestive of an active inflammatory or infectious process and presence of any known disease.
  • 3.Pregnancy or breast feeding 4.Current alcoholism or drug abuse 5.Allergies to one of the component substances in the trial 6.medication (active medication) 7.Participation in another clinical trial less than 3 months previously.

结局指标

主要结局

To assess the efficacy of herbal preparation in patients with Delayed onset muscle soreness (DOMS) due to eccentric muscle activity.

时间窗: Screening visit - day-7 day1 day2 day3 and day4

次要结局

  • To assess the safety of herbal preparation in patients with Delayed onset muscle soreness (DOMS) due to eccentric muscle activity.

研究者

发起方
Plant Lipids P limited
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验